Comparative Study of OPC-1085EL Ophthalmic Solution to Latanoprost Ophthalmic Solution 0.005% in Subjects with Primary Open-Angle Glaucoma or Ocular Hypertension (Phase 3 study)

Category Primary study
Registry of TrialsJapan Pharmaceutical Information Center
Year 2014
INTERVENTION: Intervention name : OPC‐1085EL ophthalmic solution Dosage And administration of the intervention : Ophthalmic use, once daily Control intervention name : Latanoprost ophthalmic solution Dosage And administration of the control intervention : Ophthalmic use, once daily CONDITION: Glaucoma or ocular hypertension PRIMARY OUTCOME: Intraocular pressure SECONDARY OUTCOME: Efficacy: Intraocular pressure; Safety INCLUSION CRITERIA: Subjects with bilateral primary open‐angle glaucoma or ocular hypertension
Epistemonikos ID: fb7b5df249167f6c95bd92c2715ad8c1f1cce1e3
First added on: Aug 22, 2024